The latest scientific consensus indicates that biological aging can be slowed down somewhat, and the paradigm of longevity has officially shifted from treating isolated diseases to targeting the underlying mechanisms of aging itself—a field known as geroscience. Rather than focusing purely on lifespan (how long you live), contemporary research emphasizes healthspan—the number of years lived free from chronic disease and disability.

Recent clinical studies and breakthroughs provide a clearer picture of what successfully slows biological aging.

The Big Discovery: Biological vs. Chronological Age

Scientists evaluate anti-aging interventions using “epigenetic clocks” (such as the GrimAge or PhenoAge clocks), which measure DNA methylation and proteomic biomarkers to track wear and tear at the cellular level. A landmark meta-analysis evaluating over 50 anti-aging interventions revealed which strategies actually alter these biomarkers:

• Prescription Medications Have the Highest Impact: Metabolic and weight-management drugs like metformin and semaglutide (GLP-1 agonists), alongside anti-inflammatory therapies (anti-TNF), showed the most significant impact on decreasing epigenetic age across all biomarkers.
• Lifestyle Habits Are the Most Consistent: Combined protocols of regular exercise and a structured diet (such as Mediterranean, low-carb, or low-fat) consistently lowered biological age across diverse cohorts.
• Over-the-Counter Supplements Lack Reliable Proof: Despite massive commercial marketing, the broader scientific consensus remains skeptical. Most OTC anti-aging supplements show highly inconsistent or negligible effects on epigenetic clocks compared to prescription interventions and standard lifestyle changes. However, a specific 2026 study noted that daily high-quality multivitamins might offer a very modest baseline benefit (slowing biological aging by about 4 months over a 2-year period).

Cutting-Edge Breakthroughs on the Horizon

Beyond everyday habits, several high-profile clinical milestones show that cellular age might not just be slowed, but partially reset:

• The First Human Cellular Reprogramming Trials: Groundbreaking biotech trials have transitioned from animal models into humans. Using partial epigenetic reprogramming—a technique utilizing Yamanaka factors to reset older cells back to a younger state without stripping away their identity—scientists are attempting to reverse age-related vision loss caused by glaucoma.
• Repurposed Disease Therapeutics: Experimental drugs like rentosertib (originally designed for lung disease) have inadvertently demonstrated systemic longevity benefits in early human trials, shaving off an estimated three to four years of biological age by altering key blood proteins.
• Mitochondrial and Immune System Restoration: Lab breakthroughs at institutions like Stanford University have successfully targeted organ aging by blocking specific cell receptors to restore tissue-resident macrophages (immune cells). This clears out dead cell buildup and drastically lowers the chronic inflammation—often termed “inflammaging”—that drives organ degradation.

Longevity

Experts emphasize that the absolute foundation for longevity still relies on multi-domain, accessible habits. In comprehensive surveys, researchers underscore that optimizing functional fitness (tracking metrics like VO2 max and grip strength) and fostering deep social connections are more effective at delaying dementia and physical frailty than any trending biohacks.